Victory Capital Management
TNGX icon

Victory Capital Management’s Tango Therapeutics TNGX Stock Holding History

Victory Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Buy
52,801
+42,595
+417% +$593K ﹤0.01% 1798
2025
Q4 		$90.4K Buy
+10,206
New +$87.9K ﹤0.01% 2278
2024
Q2 		– Sell
-58,180
Closed -$462K – 2533
2024
Q1 		$462K Sell
58,180
-14,460
-20% -$155K ﹤0.01% 2011
2023
Q4 		$719K Buy
+72,640
New +$631K ﹤0.01% 1859
2021
Q4 		– Sell
-11,022
Closed -$143K – 2846
2021
Q3 		$143K Buy
+11,022
New +$132K ﹤0.01% 2582

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Victory Capital Management's TNGX Position: Q1 2026 in Review

Victory Capital Management increased its Tango Therapeutics (TNGX) stake by 417% in Q1 2026, buying an estimated $593K and bringing the position to 52,801 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1798.

Victory Capital Management first reported a position in TNGX in Q3 2021 and has held it in 5 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Victory Capital Management held 52,801 shares of Tango Therapeutics worth $1.1M as of Q1 2026.
  • Victory Capital Management bought 42,595 Tango Therapeutics shares in Q1 2026, an estimated $593K.
  • Tango Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1798 holding.
  • Victory Capital Management first reported a position in Tango Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.